Hormone-Receptor Positive Breast Cancer
VIDEO: Study investigates HER2-low, ultralow eligibility for trastuzumab deruxtecan
SAN ANTONIO — In this video, Raza Hoda, MD, discusses results from the DESTINY-Breast04 and DESTINY-Breast06 trials presented at San Antonio Breast Cancer Symposium.
VIDEO: Study shows antibody-drug conjugate efficacy against HER2-low, HER2-ultralow tumors
SAN ANTONIO — In this video, Patrick McIntire, MD, discusses findings from the DESTINY-Breast04 and DESTINY-Breast06 trials presented at San Antonio Breast Cancer Symposium.
New endocrine therapy options for patients with breast cancer on the horizon, expert says
Endocrine therapies have revolutionized the field of breast cancer, with significant improvements in survival outcomes among patients with hormone receptor-positive disease.
VIDEO: SABCS includes ‘exciting’ research in HR-positive breast cancer
In this video, Payal Shah, MD, assistant professor of medicine at the hospital of the University of Pennsylvania, discusses some of the highlights in hormone receptor-positive breast cancer presented at this year’s San Antonio Breast Cancer Symposium.